Last checked at 17 Jul 2009 08:44
Allergy Therapeutics PLC - News Announcement - Allergy Therapeutics - Grant of Options
Allergy Therapeutics PLC
17 July 2009
Provisional Grant of Options
Allergy Therapeutics plc ('the Company') announces that, pursuant to the Allergy Therapeutics plc Long Term Share Incentive Plan ('LTIP'), on 16 July 2009 provisional shares of 0.1 pence each in the share capital of the Company were awarded to the following directors, Manuel Llobet (Executive Director), Ian Postlethwaite (Finance Director), Christian Gratz (Executive Director) and Tom Holdich (Executive Director) at nil cost, as follows:
| Director | Number of provisional shares awarded | Date of distribution | Total provisional shares held under LTIPs |
| Manuel Llobet | 750,000 | 16 July 2012 | 750,000 |
| Ian Postlethwaite | 600,000 | 16 July 2012 | 864,691 |
| Christian Gratz | 600,000 | 16 July 2012 | 893,320 |
| Tom Holdich | 600,000 | 16 July 2012 | 871,805 |
The distribution of these ordinary shares of 0.1 pence each under the LTIP is conditional on the Company's performance over the course of the next three years.
For further information
| Allergy Therapeutics Keith Carter, Chief Executive www.allergytherapeutics.com | +44 (0) 1903 845 820 |
| Nomura Code Securities Juliet Thompson/ Clare Terlouw | +44 (0) 207 776 1200 |